The Impact of Telemonitoring on Improving Glycemic and Metabolic Control in Previously Lost-to-Follow-Up Patients with Type 2 Diabetes Mellitus: A Single-Center Interventional Study in the United Arab Emirates

Table 1

Demographic characteristics and medical history of the patients.

Baseline characteristics	Mean	SD
Age	48.2	10.1
	Count	Percent
Gender
Male	16	42.1
Female	22	57.9
Medical history
Any medical history other than diabetes	38	100
Vitamin D deficiency	36	94.7
Dyslipidemia	34	89.5
Obesity	27	71.1
Hypertension	23	60.5
CKD	14	36.8
Microalbumin	9	64.3
Proteinuria	5	35.7
Hypothyroidism	8	21.1
Coronary artery disease	5	13.2
Neuropathy	4	10.5
Prior T2DM medications	Median	IQR
Number of medications	2.0	3.00
Class of medications	Count	Percent
Biguanides	23	60.5
DDP4 inhibitors	21	55.3
Insulin secretagogue	15	39.5
SGLT2 inhibitors	11	28.9
Insulin	3	7.9
GLP1	2	5.3
Thiazolidinediones	2	5.3
Current T2DM medications	Median	IQR
Number of medications	4.0	1.0
Class of medications	Count	Percent
Biguanides	36	94.7
SGLT2 inhibitors	34	89.5
DDP4 inhibitors	21	55.3
Insulin secretagogue	24	63.2
Insulin	22	57.9
GLP1	18	47.4
Thiazolidinediones	2	5.3
Alpha glucosidase inhibitor	1	2.63

The percentage was calculated for a total of 14 CKD patients.